Drag a card by its title · ⚙ to size, swap or remove

The company

FibroBiologics, Inc.

FBLG · Nasdaq

Health CareBiotechnologyNot moving yet

FBLG stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 31.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 52
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $193K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 16 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months7

Sale orders, 12 months0

Buyers · sellers4 · 0

Who	Did	Shares	Traded
Pete O'HeeronCHIEF EXECUTIVE OFFICER	bought	15,872at $0.3784	4 Mar 2026filed 4 Mar 2026
Hamid KhojaChief Scientific Officer	bought	30,000at $0.38	4 Mar 2026filed 5 Mar 2026
Pete O'HeeronCHIEF EXECUTIVE OFFICER	bought	18,200at $0.4051	3 Mar 2026filed 4 Mar 2026
Jason DavisChief Financial Officer	bought	70,000at $0.4139	2 Mar 2026filed 3 Mar 2026
Pete O'HeeronCHIEF EXECUTIVE OFFICER	bought	17,428at $0.353	2 Mar 2026filed 4 Mar 2026
Ruben A. GarciaGeneral Counsel	bought	40,000at $0.3264	27 Feb 2026filed 2 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16+0 on the quarter

New · exited3 · 4

Reported value$270K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Cascade Financial Partners, LLCadded · filed 4 Aug 2026	108,828$103K	+92,400+562.5%
Fund Evaluation Group, LLCunchanged · filed 7 Aug 2026	51,794$49K	00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	30,299$29K	+690+2.3%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026	27,769$26K	-39,896−59.0%
Qube Research & Technologies Ltdnew · filed 14 Aug 2026	24,313$23K	+24,313
BlackRock, Inc.reduced · filed 7 Aug 2026	18,238$17K	-6,409−26.0%
BARCLAYS PLCnew · filed 14 Aug 2026	7,243$6,864	+7,243
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026	6,380$6,048	00.0%
Tower Research Capital LLC (TRC)added · filed 11 Aug 2026	4,728$4,481	+4,268+927.8%
OSAIC HOLDINGS, INC.added · filed 14 Aug 2026	2,404$2,282	+2,250+1461.0%